{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:25Z","timestamp":1787440945874,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017778","name":"The Public Foundation of Chubu Science and Technology Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013642","name":"Japan Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011611","name":"Shinshu Public Utility Foundation for Promotion of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011611","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"Senshin Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004051","name":"Kato Memorial Bioscience Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011746","name":"The NOVARTIS Foundation (Japan) for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119561","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:35:31Z","timestamp":1781138131000},"page":"119561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u03b2-Arrestin-biased activation of type I angiotensin II receptors improves prognosis of murine pediatric heart failure"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-341X","authenticated-orcid":false,"given":"Hiroyuki","family":"Kawagishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takero","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-4474","authenticated-orcid":false,"given":"Takuro","family":"Numaga-Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachio","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-1144","authenticated-orcid":false,"given":"Naoto","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-7170","authenticated-orcid":false,"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-9304","authenticated-orcid":false,"given":"Hiroyuki","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119561_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","article-title":"Heart failure in pediatric patients with congenital heart disease","volume":"120","author":"Hinton","year":"2017","journal-title":"Circ. Res"},{"issue":"7","key":"10.1016\/j.biopha.2026.119561_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119561_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.jvca.2016.05.029","article-title":"Low-cardiac-output syndrome after cardiac surgery","volume":"31","author":"Lomivorotov","year":"2017","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"22","key":"10.1016\/j.biopha.2026.119561_bib4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.123.066605","article-title":"Sacubitril\/Valsartan in pediatric heart failure (PANORAMA-HF): a randomized, multicenter, double-blind trial","volume":"150","author":"Shaddy","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.biopha.2026.119561_bib5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119561_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00109-012-0894-z","article-title":"Emergence and evolution of the renin-angiotensin-aldosterone system","volume":"90","author":"Fournier","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119561_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.ph.43.030181.002103","article-title":"Factors affecting changes in the neonatal systemic circulation","volume":"43","author":"Heymann","year":"1981","journal-title":"Annu Rev. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119561_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1113\/jphysiol.1974.sp010769","article-title":"Factors influencing plasma renin and angiotensin II in the conscious pregnant ewe and its foetus","volume":"243","author":"Pipkin","year":"1974","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119561_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.RES.48.2.183","article-title":"Effects of angiotensin II on the blood flow and its distribution in fetal lambs","volume":"48","author":"Iwamoto","year":"1981","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119561_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/634240","article-title":"Effect of angiotensin II on the left ventricular function in a near-term fetal sheep with metabolic acidemia","volume":"2011","author":"Acharya","year":"2011","journal-title":"J. Pregnancy"},{"issue":"3","key":"10.1016\/j.biopha.2026.119561_bib11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119561_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12872-025-04756-y","article-title":"Heart failure outcomes in Sub-Saharan Africa: a scoping review of recent studies conducted after the 2022 AHA\/ACC\/HFSA guideline release","volume":"25","author":"Siddikatou","year":"2025","journal-title":"BMC Cardiovasc. Disord."},{"issue":"13","key":"10.1016\/j.biopha.2026.119561_bib13","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1113\/JP273883","article-title":"Angiotensin II activates Ca(V) 1.2 Ca(2+) channels through beta-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes","volume":"595","author":"Kashihara","year":"2017","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119561_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/jpet.110.173005","article-title":"Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance","volume":"335","author":"Violin","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.119561_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacbts.2020.08.011","article-title":"beta-arrestin-biased AT(1) agonist TRV027 causes a neonatal-specific sustained positive inotropic effect without increasing heart rate","volume":"5","author":"Kashihara","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119561_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tibs.2024.03.006","article-title":"Beneath the surface: endosomal GPCR signaling","volume":"49","author":"Flores-Espinoza","year":"2024","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.biopha.2026.119561_bib17","series-title":"Excitation-Contraction Coupling and Cardiac Contractile Force","first-page":"323","article-title":"Sites for induction of cardiac inotropy","author":"Bers","year":"2008"},{"issue":"18","key":"10.1016\/j.biopha.2026.119561_bib18","first-page":"3231","article-title":"Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells","volume":"142","author":"van den Berg","year":"2015","journal-title":"Development"},{"issue":"12","key":"10.1016\/j.biopha.2026.119561_bib19","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","article-title":"Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications","volume":"120","author":"Yoshida","year":"2017","journal-title":"Circ. Res"},{"issue":"30","key":"10.1016\/j.biopha.2026.119561_bib20","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/eurheartj\/ehx196","article-title":"Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)","volume":"38","author":"Pang","year":"2017","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.biopha.2026.119561_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.106.146670","article-title":"Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation","volume":"101","author":"Du","year":"2007","journal-title":"Circ. Res."},{"issue":"9386","key":"10.1016\/j.biopha.2026.119561_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.biopha.2026.119561_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Committees, Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.biopha.2026.119561_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Committees, Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.biopha.2026.119561_bib25","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119561_bib26","doi-asserted-by":"crossref","first-page":"H1525","DOI":"10.1152\/ajpheart.00890.2014","article-title":"Best anesthetics for assessing left ventricular systolic function by echocardiography in mice","volume":"308","author":"Pachon","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119561_bib27","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00000539-200005000-00011","article-title":"The effect of alpha(2) agonist-induced sedation and its reversal with an alpha(2) antagonist on organ blood flow in sheep","volume":"90","author":"Talke","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2026.119561_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","article-title":"Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken","volume":"53","author":"Fridericia","year":"1920","journal-title":"Acta Med. Scand. 1920"},{"key":"10.1016\/j.biopha.2026.119561_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ab.2014.05.022","article-title":"Direct chemiluminescent enzyme immunoassay for atrial natriuretic peptide in mammalian plasma using a PEGylated antibody","volume":"461","author":"Nagai","year":"2014","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119561_bib30","doi-asserted-by":"crossref","first-page":"L1099","DOI":"10.1152\/ajplung.00217.2007","article-title":"Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice","volume":"293","author":"Bland","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119561_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167348","article-title":"Electrophysiological characteristics of human iPSC-derived cardiomyocytes for the assessment of drug-induced proarrhythmic potential","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLOS One"},{"issue":"7","key":"10.1016\/j.biopha.2026.119561_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1248\/bpb.b22-00268","article-title":"Proarrhythmia risk assessment using electro-mechanical window in human iPS cell-derived cardiomyocytes","volume":"45","author":"Yanagida","year":"2022","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2026.119561_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119561_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfac095","article-title":"Use of human iPSC-CMs in nonclinical regulatory studies for cardiac safety assessment","volume":"190","author":"Yang","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119561_bib35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jcph.111","article-title":"First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers","volume":"53","author":"Soergel","year":"2013","journal-title":"J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119561_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.kint.2016.11.003","article-title":"Angiotensin II-AT1-receptor signaling is necessary for cyclooxygenase-2-dependent postnatal nephron generation","volume":"91","author":"Frolich","year":"2017","journal-title":"Kidney Int"},{"issue":"1 Pt 2","key":"10.1016\/j.biopha.2026.119561_bib37","first-page":"F110","article-title":"Angiotensin II regulates nephrogenesis and renal vascular development","volume":"269","author":"Tufro-McReddie","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119561_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-201X.2004.01327.x","article-title":"The renin-angiotensin system in kidney development","volume":"181","author":"Chen","year":"2004","journal-title":"Acta Physiol. Scand."},{"issue":"1","key":"10.1016\/j.biopha.2026.119561_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/apha.12088","article-title":"Postnatal development of the renal medulla; role of the renin-angiotensin system","volume":"208","author":"Madsen","year":"2013","journal-title":"Acta Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119561_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008912","article-title":"Elevated potassium levels in patients with congestive heart failure: occurrence, risk factors, and clinical outcomes: a Danish population-based cohort study","volume":"7","author":"Thomsen","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2026.119561_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.ctdb.2015.10.010","article-title":"Development of the mammalian kidney","volume":"117","author":"McMahon","year":"2016","journal-title":"Curr. Top. Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119561_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ydbio.2011.09.011","article-title":"Nephron formation adopts a novel spatial topology at cessation of nephrogenesis","volume":"360","author":"Rumballe","year":"2011","journal-title":"Dev. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119561_bib43","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0022-2828(91)91638-8","article-title":"Angiotensin II and left ventricular growth in newborn pig heart","volume":"23","author":"Beinlich","year":"1991","journal-title":"J. Mol. Cell Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119561_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1203\/00006450-200209000-00004","article-title":"Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart","volume":"52","author":"Choi","year":"2002","journal-title":"Pediatr. Res."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2026.119561_bib45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1113\/jphysiol.2003.038778","article-title":"Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes","volume":"548","author":"Sundgren","year":"2003","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119561_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.RES.74.2.206","article-title":"Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart","volume":"74","author":"Ungerer","year":"1994","journal-title":"Circ. Res"},{"issue":"5","key":"10.1016\/j.biopha.2026.119561_bib47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/HYPERTENSIONAHA.117.09817","article-title":"beta-Arrestin2 improves post-myocardial infarction heart failure via sarco(endo)plasmic reticulum Ca(2+)-ATPase-dependent positive inotropy in cardiomyocytes","volume":"70","author":"McCrink","year":"2017","journal-title":"Hypertension"},{"issue":"28","key":"10.1016\/j.biopha.2026.119561_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1606267113","article-title":"beta-arrestin-biased signaling through the beta2-adrenergic receptor promotes cardiomyocyte contraction","volume":"113","author":"Carr","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.biopha.2026.119561_bib49","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cvr\/cvx147","article-title":"beta-arrestin 2 mediates cardiac ischemia-reperfusion injury via inhibiting GPCR-independent cell survival signalling","volume":"113","author":"Wang","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"29","key":"10.1016\/j.biopha.2026.119561_bib50","doi-asserted-by":"crossref","first-page":"47317","DOI":"10.18632\/oncotarget.17636","article-title":"MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and beta-arrestin 2","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2026.119561_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pharmthera.2008.11.005","article-title":"Physiological and pharmacological implications of beta-arrestin regulation","volume":"121","author":"Schmid","year":"2009","journal-title":"Pharm. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119561_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jjcc.2021.11.021","article-title":"Pathophysiological role of right ventricular function and interventricular functional mismatch in the development of pulmonary edema in acute heart failure","volume":"79","author":"Yamamoto","year":"2022","journal-title":"J. Cardiol."},{"key":"10.1016\/j.biopha.2026.119561_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jss.2019.05.048","article-title":"Right ventricular involution: big changes in small hearts","volume":"243","author":"Bowen","year":"2019","journal-title":"J. Surg. Res"},{"issue":"11","key":"10.1016\/j.biopha.2026.119561_bib54","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/00003246-199511000-00018","article-title":"Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery","volume":"23","author":"Chang","year":"1995","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119561_bib55","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.0000051365.81920.28","article-title":"Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease","volume":"107","author":"Hoffman","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2026.119561_bib56","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"I. Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure, short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119561_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCHEARTFAILURE.114.001218","article-title":"Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy","volume":"8","author":"Nakano","year":"2015","journal-title":"Circ. Heart Fail."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:53:37Z","timestamp":1787439217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S0753332226005974"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119561","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Arrestin-biased activation of type I angiotensin II receptors improves prognosis of murine pediatric heart failure","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119561"}}